Výsledky vyhledávání - "Barbara Szechtman"

Factors Associated With Thrombotic Complications After the Fontan Procedure

Autor: Marina L. Hughes, Robin S. Roberts, Andrew D. Cochrane, Paul Monagle, Barbara Szechtman, Maureen Andrew, Cedric Manlhiot, Brian W. McCrindle, Robert G. Weintraub

Publikováno v: Journal of the American College of Cardiology. 61(3):346-353

Objectives The study sought to identify factors associated with increased risk of thrombosis after Fontan. Background The Fontan procedure is the culmination of staged palliation for patients with univentricular physiology. Thrombosis is an important

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b68442d7dbac371ad7b3fe02dc33ea

Zobrazit plný text záznamu

Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia

Autor: Mark Levine, Barbara Szechtman, Wilson Roa, Kathleen I. Pritchard, Bruno Gagnon, Column Smith, James R. Wright, Jim A. Julian, Yee C. Ung, Timothy J. Whelan, Liam Mulroy, Rudinskas L, Gord S. Okawara

Publikováno v: Journal of Clinical Oncology. 25:1027-1032

Purpose Previous trials have suggested a quality-of-life (QOL) improvement for anemic cancer patients treated with erythropoietin, but few used QOL as the primary outcome. We designed a trial to investigate the effects of epoetin alfa therapy on the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aefac906a10782b2a304b38b2bce7629
https://doi.org/10.1200/jco.2006.07.1514

Zobrazit plný text záznamu

Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care

Autor: Timothy J. Whelan, David Ginsburg, Kathleen I. Pritchard, Doug Mirsky, Jim A. Julian, Carol Sawka, Susan Dent, Shailendara Verma, Eva Grunfeld, Barbara Szechtman, Doug Coyle, Marjorie Wood, Mark Levine

Publikováno v: Journal of Clinical Oncology. 24:848-855

Purpose Most women with breast cancer are diagnosed at an early stage and more than 80% will be long-term survivors. Routine follow-up marks the transition from intensive treatment to survivorship. It is usual practice for routine follow-up to take p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e3c5b7aa7497d4bfe36add98c9974041
https://doi.org/10.1200/jco.2005.03.2235

Zobrazit plný text záznamu

Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin–sodium) in pediatric patients

Autor: Anthony K.C. Chan, Maureen Andrew, Michael Gent, Patricia Massicotte, Jim A. Julian, Velma Marzinotto, Peter Bacher, Steven Kohne, Barbara Szechtman, Karen Shields, Steven Shepherd

Publikováno v: Thrombosis Research. 109:93-99

Introduction: The low molecular weight heparin (LMWH), reviparin–sodium was studied in dose-finding and pharmacokinetic studies in children with central venous lines (CVLs). Materials and methods: The dose-finding study was performed in 24 patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea3c8096340fcc2374e597be00c0a78f
https://doi.org/10.1016/s0049-3848(03)00100-2

Zobrazit plný text záznamu

Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure

Autor: Brian W, McCrindle, Cedric, Manlhiot, Andrew, Cochrane, Robin, Roberts, Marina, Hughes, Barbara, Szechtman, Robert, Weintraub, Maureen, Andrew, Paul, Monagle

Publikováno v: Journal of the American College of Cardiology. 61(3)

The study sought to identify factors associated with increased risk of thrombosis after Fontan.The Fontan procedure is the culmination of staged palliation for patients with univentricular physiology. Thrombosis is an important complication after thi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4c5242cf30462210dc5c590511cdc2ee
https://pubmed.ncbi.nlm.nih.gov/23246388

Zobrazit plný text záznamu

A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children

Autor: Brian W. McCrindle, Andrew D. Cochrane, Barbara Szechtman, Robert G. Weintraub, Marina Hughes, Maureen Andrew, Cedric Manlhiot, Paul Monagle, Robin S. Roberts

Publikováno v: Journal of the American College of Cardiology. 58(6)

Objectives The purpose of this study was to compare the safety and efficacy of acetylsalicylic acid (ASA) and warfarin for thromboprophylaxis after the Fontan procedure. Background Fontan surgery is the definitive palliation for children with single-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae45e9aabc1b83edf2f456e8dba0c9c
https://pubmed.ncbi.nlm.nih.gov/21798430

Zobrazit plný text záznamu

Regional Brain Metabolism During Auditory Hallucinations in Chronic Schizophrenia

Autor: Stanley W. Dermer, C. Nahmias, Gregory M. Brown, S Franco, E.S. Garnett, Barbara Szechtman, Henry Szechtman, Ronald D. Kaplan, John M. Cleghorn, P. Cook

Publikováno v: Scopus-Elsevier

Regions of the brain involved in language and attention were studied using [18F]-fluorodeoxyglucose in PET. In nine chronic DSM–III schizophrenic patients who had persistent auditory hallucinations, ten who had recovered from hallucinations and ten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::525457c45200a6e927d70627dda4a276
https://doi.org/10.1192/bjp.157.4.562

Zobrazit plný text záznamu

Dose-response profiles of plasma growth hormone and vasopressin after clonidine challenge in man

Autor: Gregory M. Brown, John M. Cleghorn, Michael F. Mazurek, Deborah T. Allen, Barbara Szechtman

Publikováno v: Psychiatry Research. 31:311-320

The objective of the study was to determine dose-response relationships of growth hormone, vasopressin, blood pressure, heart rate, and behavioral responses to clonidine. Ten healthy male volunteers were tested with each of three doses of clonidine (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c24996d2ecde8752888f2db99f67e733
https://doi.org/10.1016/0165-1781(90)90100-j

Zobrazit plný text záznamu

An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial

Autor: Velma Marzinotto, Patricia Massicotte, Maureen Andrew, Barbara Szechtman, Karen Shields, Jim A. Julian, Michael Gent

Publikováno v: Thrombosis research. 109(2-3)

Objective(s): Venous thromboembolic events (VTE) are serious complications in children and for which the standard of care, unfractionated heparin followed by oral anticoagulation (UFH/OA), is problematic. The objective of REVIVE was to compare the ef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da5615dcb7b9d68c08f58ab643eadf2
https://pubmed.ncbi.nlm.nih.gov/12706636

Zobrazit plný text záznamu

An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial

Autor: Patricia Massicotte, Michael Gent, Jim A. Julian, Karen Shields, Maureen Andrew, Velma Marzinotto, Barbara Szechtman, Anthony K.C. Chan

Publikováno v: Thrombosis research. 109(2-3)

Objective(s): Central venous lines (CVLs) are major risk factors for venous thromboembolism (VTE) in children. The objective of PROTEKT was to determine if a low molecular weight heparin (reviparin-sodium) safely prevents CVL-related VTE. Study desig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be58a4cece2f7bdc50716ec9b8bbc0a4
https://pubmed.ncbi.nlm.nih.gov/12706638

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání